These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12384510)
1. Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. Stamatakis K; Cernuda-Morollón E; Hernández-Perera O; Pérez-Sala D J Biol Chem; 2002 Dec; 277(51):49389-96. PubMed ID: 12384510 [TBL] [Abstract][Full Text] [Related]
3. Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB. Holstein SA; Wohlford-Lenane CL; Hohl RJ J Biol Chem; 2002 Mar; 277(12):10678-82. PubMed ID: 11788600 [TBL] [Abstract][Full Text] [Related]
4. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells. Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834 [TBL] [Abstract][Full Text] [Related]
5. Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin. Von Zee CL; Richards MP; Bu P; Perlman JI; Stubbs EB Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2816-23. PubMed ID: 19151402 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal. Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells. Hernández-Perera O; Pérez-Sala D; Soria E; Lamas S Circ Res; 2000 Sep; 87(7):616-22. PubMed ID: 11009568 [TBL] [Abstract][Full Text] [Related]
8. Statins reduce amyloid-beta production through inhibition of protein isoprenylation. Ostrowski SM; Wilkinson BL; Golde TE; Landreth G J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164 [TBL] [Abstract][Full Text] [Related]
9. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313 [TBL] [Abstract][Full Text] [Related]
10. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Maeda T; Kawane T; Horiuchi N Endocrinology; 2003 Feb; 144(2):681-92. PubMed ID: 12538631 [TBL] [Abstract][Full Text] [Related]
11. Prenylation of Rho G-proteins: a novel mechanism regulating gene expression and protein stability in human trabecular meshwork cells. Stubbs EB; Von Zee CL Mol Neurobiol; 2012 Aug; 46(1):28-40. PubMed ID: 22396212 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells. Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337 [TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy. Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products. Liang YJ; Shyu KG; Wang BW; Lai LP Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the mevalonate pathway by simvastatin interferes with mast cell degranulation by disrupting the interaction between Rab27a and double C2 alpha proteins. Sahid MNA; Liu S; Kiyoi T; Maeyama K Eur J Pharmacol; 2017 Nov; 814():255-263. PubMed ID: 28864210 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin inhibits protein isoprenylation in the brain. Ostrowski SM; Johnson K; Siefert M; Shank S; Sironi L; Wolozin B; Landreth GE; Ziady AG Neuroscience; 2016 Aug; 329():264-74. PubMed ID: 27180285 [TBL] [Abstract][Full Text] [Related]
17. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Kotamraju S; Williams CL; Kalyanaraman B Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209 [TBL] [Abstract][Full Text] [Related]
18. Involvement of geranylgeranylation of Rho and Rac GTPases in adipogenic and RANKL expression, which was inhibited by simvastatin. Baba TT; Ohara-Nemoto Y; Miyazaki T; Nemoto TK Cell Biochem Funct; 2013 Dec; 31(8):652-9. PubMed ID: 23339033 [TBL] [Abstract][Full Text] [Related]
19. FBXW7 regulates endothelial barrier function by suppression of the cholesterol synthesis pathway and prenylation of RhoB. Pronk MCA; Majolée J; Loregger A; van Bezu JSM; Zelcer N; Hordijk PL; Kovačević I Mol Biol Cell; 2019 Mar; 30(5):607-621. PubMed ID: 30601691 [TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase. Wherlock M; Gampel A; Futter C; Mellor H J Cell Sci; 2004 Jul; 117(Pt 15):3221-31. PubMed ID: 15226397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]